Neurosense Therapeutics News - September 2026
🟢 Neurosense Therapeutics is trading 13.37% up today amid a broader biotechnology rally
Neurosense Therapeutics is trading 13.37% up at $6.91, amid a broader risk-on session lifting biotechnology stocks. - Major U.S. indexes are higher as...
🔴 Neurosense Therapeutics is trading 14% down today following 1-for-20 reverse stock split
Neurosense Therapeutics is trading 14.01% down now at $6.04 after heightened volatility following its 1-for-20 reverse stock split, effective September 14,...
🟢 Neurosense Therapeutics is trading 9.56% up today after HC Wainwright initiated Buy-rated coverage
Neurosense Therapeutics is trading 9.56% up now at $0.44 after HC Wainwright initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...
🟢 Neurosense Therapeutics is trading 8.69% up today after HC Wainwright initiated Buy-rated coverage
Neurosense Therapeutics is trading 8.69% up now at $0.45 after HC Wainwright initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...
🟢 Neurosense Therapeutics is trading 12% up in pre-market after HC Wainwright initiated Buy-rated coverage
Neurosense Therapeutics is trading 11.93% up at $0.46 after HC Wainwright & Co. initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...
🟢 Neurosense Therapeutics Surges in Pre-Market on HC Wainwright & Co. 'Buy' Rating and Redesigned PrimeC ALS Strategy
- Neurosense Therapeutics is trading 7.32% up in pre-market at $0.44 following HC Wainwright & Co. initiating coverage with a 'Buy' rating and an $8.00 price...